From SEC EDGAR

SiTime Reports Third Quarter 2026 Financial Results

Q3 Net Revenue Increased 257% to $298.7 Million

ParkOhio Announces Record Sales and Strong Third Quarter 2026 Results;

Raises FY 2026 Sales and Adjusted EPS Outlook on Continued Strong Demand Across Its Diversified End Markets

Klaviyo Delivers Solid Q3 with Enterprise Growth, Multi-Product Strength, and Agent Traction

Third quarter revenue of $387.2 million, representing 25% year-over-year growth

Silvaco Reports Third Quarter 2026 Financial Results

Won major new tier-1 FTCO customer and 4 tier-1 customers for Jivaro Pro in Q3

Excelerate Energy, Inc.

Excelerate Energy Reports Strong Third Quarter 2026 Results

ENCORE CAPITAL GROUP INC

Encore Capital Group Announces Third Quarter 2026 Financial Results

Press Release

Bio-Rad Reports Third-Quarter 2026 Financial Results

Dave Reports Third Quarter 2026 Financial Results

Q3 Revenue Growth Accelerates to 31% Y/Y to $198 Million, Driven by Record New Member Acquisition as well as Continued MTM Growth and ARPU Expansion

TRUEBLUE REPORTS THIRD QUARTER 2026 RESULTS

CrossAmerica Partners LP Reports Third Quarter 2026 Results

Reported Third Quarter of 2026 Net Income of $8.8 million, Adjusted EBITDA of $38.7 million and Distributable Cash Flow of $21.8 million compared to…

HMH Holding Inc. Announces Third Quarter 2026 Results

HOST HOTELS & RESORTS, INC.

Host Hotels & Resorts, Inc. Reports Results for the Third Quarter of 2026

Ascent Industries Reports Third Quarter 2026 Results; Year-Over-Year Net Sales Increase 37.8%, Including 26.3% Growth in Sales Excluding the Midwest Graphic Sales Acquisition; Adjusted EBITDA Improves by $2.1 Million

Sequentially, net sales increased 5.7%, gross profit increased 28.3% and

Arcutis Announces Third Quarter 2026 Financial Results and Provides Business Update

Ingevity Corp

Ingevity reports third quarter 2026 financial results

Ex 99.1

PTC Announces Fourth fiscal Quarter and Full Fiscal YEar 2026 Results

Rapid7 Announces Third Quarter 2026 Financial Results

•Annualized recurring revenue (“ARR”) of $820 million

Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

ZoomInfo Announces Third Quarter 2026 Financial Results

Myriad Genetics Reports Third Quarter 2026 Financial Results;

Raises Mid-Point of Full-Year 2026 Revenue Guidance Following Solid Execution